Percentage of adult patients aged 25 and older with atrial fibrillation and major stroke risk factors who are on anticoagulation therapy.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting
-
1.14 Numerator
Patients with evidence of anticoagulation therapy.
-
1.15 Denominator
All patients with Atrial Fibrillation and one of the following:
1. Age greater than or equal to 25 with prior stroke, mitral stenosis or mitral valve replacement
2. Age greater than or equal to 75 and 1 of the following: diabetes, hypertension or CHF
3. Age less than 75 and 2 of the following: diabetes, hypertension or CHF
-
Exclusions
Contraindications to warfarin, including:
• Esophageal varices with bleed
• Aortic dissection
• Intracerebral hemorrhage
• Blood transfusion(RBC or platelets)
• Severe brain injury
• Dementia
• Alcohol use/abuse
• Falls
• Fracture
• Hemorrhage contraindications and procedures
• Adverse effects fromcoumadin
• Abnormal gait/incoordination
• Neuro and eye surgery
• Gastritis with Current fill of Proton pump inhibitors
• Thrombocytopenia
• Hematocrit lab value < 25
• Pregnancy
• Patient or provider feedback indicating patient has allergy, intolerance, or contraindication to the drug anytime in the past
• General exclusions:
Terminal illness anytime in the past
hospice in the past 12 months
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative DataInitial EndorsementLast UpdatedRemoval Date
-
StewardActiveHealth ManagementSteward Organization POC Email
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-